These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 22052512

  • 21. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
    Liu H, Wang Y, Xiao Y, Hua Z, Cheng J, Jia J.
    Transl Stroke Res; 2016 Jun; 7(3):209-19. PubMed ID: 27018013
    [Abstract] [Full Text] [Related]

  • 22. Therapeutic benefits of combined treatment with tissue plasminogen activator and 2-(4-methoxyphenyl)ethyl-2-acetamido-2-deoxy-β-d-pyranoside in an animal model of ischemic stroke.
    Yu S, Liu X, Shen Y, Xu H, Yang Y, Ding F.
    Neuroscience; 2016 Jul 07; 327():44-52. PubMed ID: 27060484
    [Abstract] [Full Text] [Related]

  • 23. Lost in translation: taking neuroprotection from animal models to clinical trials.
    Hoyte L, Kaur J, Buchan AM.
    Exp Neurol; 2004 Aug 07; 188(2):200-4. PubMed ID: 15246820
    [Abstract] [Full Text] [Related]

  • 24. Preconditioning and post-treatment with cobalt chloride in rat model of perinatal hypoxic-ischemic encephalopathy.
    Dai Y, Li W, Zhong M, Chen J, Liu Y, Cheng Q, Li T.
    Brain Dev; 2014 Mar 07; 36(3):228-40. PubMed ID: 23694759
    [Abstract] [Full Text] [Related]

  • 25. Glial growth factor 2 promotes functional recovery with treatment initiated up to 7 days after permanent focal ischemic stroke.
    Iaci JF, Ganguly A, Finklestein SP, Parry TJ, Ren J, Saha S, Sietsma DK, Srinivas M, Vecchione AM, Caggiano AO.
    Neuropharmacology; 2010 Dec 07; 59(7-8):640-9. PubMed ID: 20691195
    [Abstract] [Full Text] [Related]

  • 26. Neuroprotection in transient focal cerebral ischemia by combination drug therapy and mild hypothermia: comparison with customary therapeutic regimen.
    Zausinger S, Westermaier T, Plesnila N, Steiger HJ, Schmid-Elsaesser R.
    Stroke; 2003 Jun 07; 34(6):1526-32. PubMed ID: 12730554
    [Abstract] [Full Text] [Related]

  • 27. Strategies to improve post-stroke behavioral recovery in aged subjects.
    Buga AM, Bălşeanu A, Popa-Wagner A, Mogoantă L.
    Rom J Morphol Embryol; 2009 Jun 07; 50(4):559-82. PubMed ID: 19942950
    [Abstract] [Full Text] [Related]

  • 28. Effect of the duration of middle cerebral artery occlusion on the risk of hemorrhagic transformation after tissue plasminogen activator injection in rats.
    Copin JC, Gasche Y.
    Brain Res; 2008 Dec 03; 1243():161-6. PubMed ID: 18835259
    [Abstract] [Full Text] [Related]

  • 29. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
    Belayev L, Khoutorova L, Deisher TA, Belayev A, Busto R, Zhang Y, Zhao W, Ginsberg MD.
    Stroke; 2003 Mar 03; 34(3):758-63. PubMed ID: 12624304
    [Abstract] [Full Text] [Related]

  • 30. Effects of tissue plasminogen activator timing on blood-brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke.
    Zhang Y, Wang Y, Zuo Z, Wang Z, Roy J, Hou Q, Tong E, Hoffmann A, Sperberg E, Bredno J, Berr SS, Xie M, Lee K, Wintermark M.
    J Neurol Sci; 2014 Dec 15; 347(1-2):148-54. PubMed ID: 25292413
    [Abstract] [Full Text] [Related]

  • 31. Synergistic effect of an endothelin type A receptor antagonist, S-0139, with rtPA on the neuroprotection after embolic stroke.
    Zhang RL, Zhang C, Zhang L, Roberts C, Lu M, Kapke A, Cui Y, Ninomiya M, Nagafuji T, Albala B, Zhang ZG, Chopp M.
    Stroke; 2008 Oct 15; 39(10):2830-6. PubMed ID: 18669895
    [Abstract] [Full Text] [Related]

  • 32. Preconditioning with the traditional Chinese medicine Huang-Lian-Jie-Du-Tang initiates HIF-1α-dependent neuroprotection against cerebral ischemia in rats.
    Zhang Q, Bian H, Li Y, Guo L, Tang Y, Zhu H.
    J Ethnopharmacol; 2014 Jun 11; 154(2):443-52. PubMed ID: 24751364
    [Abstract] [Full Text] [Related]

  • 33. Adjuvant therapies using normobaric oxygen with hypothermia or ethanol for reducing hyperglycolysis in thromboembolic cerebral ischemia.
    Cai L, Stevenson J, Peng C, Xin R, Rastogi R, Liu K, Geng X, Gao Z, Ji X, Rafols JA, Ji Z, Ding Y.
    Neuroscience; 2016 Mar 24; 318():45-57. PubMed ID: 26794589
    [Abstract] [Full Text] [Related]

  • 34. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results.
    Ginsberg MD, Hill MD, Palesch YY, Ryckborst KJ, Tamariz D.
    Stroke; 2006 Aug 24; 37(8):2100-6. PubMed ID: 16809571
    [Abstract] [Full Text] [Related]

  • 35. Reduction in programmed cell death and improvement in functional outcome of transient focal cerebral ischemia after administration of granulocyte-macrophage colony-stimulating factor in rats. Laboratory investigation.
    Kong T, Choi JK, Park H, Choi BH, Snyder BJ, Bukhari S, Kim NK, Huang X, Park SR, Park HC, Ha Y.
    J Neurosurg; 2009 Jul 24; 111(1):155-63. PubMed ID: 19361262
    [Abstract] [Full Text] [Related]

  • 36. Cilostazol reduces the risk of hemorrhagic infarction after administration of tissue-type plasminogen activator in a murine stroke model.
    Kasahara Y, Nakagomi T, Matsuyama T, Stern D, Taguchi A.
    Stroke; 2012 Feb 24; 43(2):499-506. PubMed ID: 22033992
    [Abstract] [Full Text] [Related]

  • 37. Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat.
    Candelario-Jalil E, González-Falcón A, García-Cabrera M, León OS, Fiebich BL.
    Brain Res; 2004 May 08; 1007(1-2):98-108. PubMed ID: 15064140
    [Abstract] [Full Text] [Related]

  • 38. The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis.
    Doeppner TR, Mlynarczuk-Bialy I, Kuckelkorn U, Kaltwasser B, Herz J, Hasan MR, Hermann DM, Bähr M.
    Brain; 2012 Nov 08; 135(Pt 11):3282-97. PubMed ID: 23169919
    [Abstract] [Full Text] [Related]

  • 39. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis.
    Palesch YY, Hill MD, Ryckborst KJ, Tamariz D, Ginsberg MD.
    Stroke; 2006 Aug 08; 37(8):2107-14. PubMed ID: 16809570
    [Abstract] [Full Text] [Related]

  • 40. Administration of melatonin after onset of ischemia reduces the volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model.
    Pei Z, Pang SF, Cheung RT.
    Stroke; 2003 Mar 08; 34(3):770-5. PubMed ID: 12624306
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.